Phase IIa trial in Duchenne Muscular Dystrophy shows vamorolone is a firs-in- class dissociative steroidal anti-inflammatory drug.

LS Conklin, JM Damsker, EP Hoffman, WJ Jusko, PD Mavroudis, BD Schwartz, LJ Mengle-Gaw, EC Smith, JK Mah, M Guglieri, Y Nego, N Kuntz, CM McDonald, T Mar, MM Ryan, R Webster, D Castro, RS Finkel, AL Smith, LP MorgenrothArrieta Aa, M Shimony, M Jaros, P Shale, JM MdDall, Hathout, K Magaraju, den Anker J van, LM Ward, A Ahmet, HR Cornish, PR Clemens

Research output: Contribution to journalArticle

Original languageEnglish (US)
JournalPharmacologic Research
Volume36
StatePublished - 2018

Cite this